|
David F. Hoffmeister is Life Technologies’ Chief Financial Officer and served as Invitrogen’s Chief Financial Officer and leader of Global Finance since October 2004. Mr. Hoffmeister held various positions over the course of 20 years with McKinsey & Company, most recently as a senior partner serving clients in the healthcare, private equity and specialty chemicals industries on strategy and organizational issues. Prior to joining McKinsey, Mr. Hoffmeister held financial positions at GTE and W.R. Grace. He is currently a board member of Celanese Corporation and chairman of the audit committee. Mr. Hoffmeister received his B.S. degree in business from the University of Minnesota and an M.B.A. from the University of Chicago. | 